Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03205826
Other study ID # CHARTIS sedation
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2018
Est. completion date January 22, 2019

Study information

Verified date April 2019
Source University Medical Center Groningen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Rationale: The Chartis® ( Pulmonx, CA, USA) measurement system is a tool to assess interlobar collateral ventilation during bronchoscopy. Assessing collateral ventilation is important when you intend to treat a patient with endobronchial valves. Chartis measurement of collateral ventilation can be performed under both conscious sedation as well as general anesthesia. There is no consensus on what is the preferred method of anesthesia for Chartis measurements in the literature.

Objective: In this project we want to investigate whether there is a difference in Chartis measurement outcomes between these two methods of anesthesia: conscious sedation and general anesthesia.

Study design: This study will be a single center observational study

Study population: The study population exists of patients with severe emphysema who undergo collateral ventilation assessment before bronchoscopic lung volume reduction treatment with one-way endobronchial valves.

Intervention: All patients will undergo two subsequent Chartis measurements. The first measurement will be performed with the patient undergoing conscious sedation and the second measurement with the patient under general anesthesia.

Main study parameters/endpoints: Our primary outcome measure is the failure rate of the Chartis collateral ventilation measurement under general anesthesia versus conscious sedation.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date January 22, 2019
Est. primary completion date January 22, 2019
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Patient is scheduled for a bronchoscopic lung volume treatment using one-way valves

- Patient has provided signed informed consent.

Exclusion Criteria:

For safety reasons patients that meet the following criteria will not be included in this study:

1. FEV1 <20%

2. RV/TLC>70%

3. pCO2 >6.5

4. RVSP>40mmHg

5. 6MWT<200m

6. Known intolerance to Lidocaine

7. Any other medical reason/condition that warrants a short procedure (physician judgement )

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Type of sedation used
All patients will undergo two subsequent Chartis measurements. The first measurement will be performed with the patient undergoing conscious sedation and the second measurement with the patient under general anesthesia.

Locations

Country Name City State
Netherlands University Medical Center Groningen Groningen

Sponsors (1)

Lead Sponsor Collaborator
University Medical Center Groningen

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Failure rate The failure rate of the Chartis collateral ventilation measurement under general anesthesia versus conscious sedation. Baseline
Secondary Chartis measurement duration To compare the duration of Chartis measurement in patients undergoing conscious sedation versus general anesthesia. Baseline
Secondary Physician feasibility To investigate qualitative assessment feasibility for the physician in patients undergoing conscious sedation or general anesthesia. Baseline
Secondary Influence severity on outcome To investigate the influence of severity of disease in patients undergoing conscious sedation or general anesthesia. Baseline
Secondary Influence collateral ventilation status on outcome To investigate outcome difference in collateral ventilation status in patients undergoing conscious sedation versus general anesthesia Baseline
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT06000696 - Healthy at Home Pilot
Recruiting NCT03285100 - The Effects of Discontinuation of Vitamin K Antagonists on the Rate of Elastin Degradation N/A
Not yet recruiting NCT05900544 - Maximizing Benefit of Lung Cancer Screening Incidental Findings of Cardiovascular, Respiratory and Breast Measures N/A
Recruiting NCT06163131 - The Effect of Treatment of Emphysema With Endobronchial Valves on the Diaphragm Mobility
Recruiting NCT06149494 - RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection Phase 2
Recruiting NCT05854550 - First in Human Study to Assess an Implant to Treat Severe Emphysema N/A
Recruiting NCT05257681 - Inter-lobar Fissure Completion in Patients With Failed Bronchoscopic Lung Volume Reduction N/A
Recruiting NCT06068647 - Ultrasound and Respiratory Physiological Signals in Lung Diseases N/A
Recruiting NCT03318406 - Post-Market BTVA Registry
Recruiting NCT04214587 - Biological Investigation of Explanted Endobronchial Lung Valves Study
Recruiting NCT04781582 - LVRS Versus BLVR in Patients With Homogenous Emphysema, CLUB-HE Trial N/A
Completed NCT04520152 - Evaluation of the Free Flow Medical Lung Tensioning Device System for the Treatment of Severe Emphysema N/A
Recruiting NCT03680495 - Steroid Resistance During COPD Exacerbations With Respiratory Failure
Active, not recruiting NCT04517916 - Zephyr Etude Post-Inscription (French Registry)
Recruiting NCT06249529 - Airway Bypass - Safety and Feasibility Study Early Phase 1
Recruiting NCT06035120 - An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema N/A
Recruiting NCT05567562 - Anti-Platelets in Chronic Obstructive Pulmonary Disease Phase 2
Withdrawn NCT04029077 - Introduction of the Vapor Treatment in The Netherlands
Recruiting NCT03755505 - The Microbiome of Sputum, Urine and Feces in Healthy Persons and Chronic Obstructive Pulmonary Disease (COPD) Patients
Completed NCT03670121 - A Pilot Study to Assess Treatment of Patients With Homogeneous Emphysema Using Sequential Segmental Bronchoscopic Thermal Vapor Ablation (NEXT STEP) N/A